Wilcox C, Knych H, Katzman S, Arthur R, Rodriguez V, Finno C
J Vet Pharmacol Ther. 2024; 47(3):187-192.
PMID: 38197553
PMC: 11052667.
DOI: 10.1111/jvp.13424.
Augustin D, Augustin D, David D, Theodas J, Derisier A
Cureus. 2022; 14(2):e22198.
PMID: 35308738
PMC: 8925934.
DOI: 10.7759/cureus.22198.
Diesch-Furlanetto T, Gabriel M, Zajac-Spychala O, Cattoni A, Hoeben B, Balduzzi A
Front Pediatr. 2021; 9:773895.
PMID: 34900873
PMC: 8652149.
DOI: 10.3389/fped.2021.773895.
Peng C, Lin W, Yeh K, Chen I, Wu W, Lin M
Tzu Chi Med J. 2021; 33(3):212-223.
PMID: 34386357
PMC: 8323641.
DOI: 10.4103/tcmj.tcmj_233_20.
Juszczak B, Sulko J
Rheumatol Int. 2021; 42(4):699-706.
PMID: 34018012
PMC: 8940851.
DOI: 10.1007/s00296-021-04886-4.
Pharmacological treatment options for low Bone Mineral Density and secondary osteoporosis in Anorexia Nervosa: A systematic review of the literature.
Robinson L, Aldridge V, Clark E, Misra M, Micali N
J Psychosom Res. 2017; 98:87-97.
PMID: 28554377
PMC: 7050204.
DOI: 10.1016/j.jpsychores.2017.05.011.
Bisphosphonate therapy for osteogenesis imperfecta.
Dwan K, Phillipi C, Steiner R, Basel D
Cochrane Database Syst Rev. 2016; 10:CD005088.
PMID: 27760454
PMC: 6611487.
DOI: 10.1002/14651858.CD005088.pub4.
Endocrine Disorders in Childhood Cancer Survivors Treated with Haemopoietic Stem Cell Transplantation.
Wei C, Albanese A
Children (Basel). 2016; 1(1):48-62.
PMID: 27417467
PMC: 4939518.
DOI: 10.3390/children1010048.
The influence of low-level laser therapy with alendronate irrigation on healing of bone defects in rats.
Akyol U, Sipal S, Demirci E, Gungormus M
Lasers Med Sci. 2015; 30(3):1141-6.
PMID: 25686915
DOI: 10.1007/s10103-015-1720-y.
Glucocorticoid-induced osteoporosis: who to treat with what agent?.
Rizzoli R, Biver E
Nat Rev Rheumatol. 2014; 11(2):98-109.
PMID: 25385412
DOI: 10.1038/nrrheum.2014.188.
Osteogenesis imperfecta: a case report and review of literature.
Edelu B, Ndu I, Asinobi I, Obu H, Adimora G
Ann Med Health Sci Res. 2014; 4(Suppl 1):S1-5.
PMID: 25031897
PMC: 4083720.
DOI: 10.4103/2141-9248.131683.
Pamidronate alters the growth plate in the oim mouse model for osteogenesis imperfecta.
Evans K, Sheppard L, Rao S, Martin R, Oberbauer A
Int J Biomed Sci. 2013; 5(4):345-52.
PMID: 23675157
PMC: 3614807.
Changing pattern of femoral fractures in osteogenesis imperfecta with prolonged use of bisphosphonates.
Nicolaou N, Agrawal Y, Padman M, Fernandes J, Bell M
J Child Orthop. 2013; 6(1):21-7.
PMID: 23450103
PMC: 3303010.
DOI: 10.1007/s11832-011-0380-0.
Therapeutic impact of low amplitude high frequency whole body vibrations on the osteogenesis imperfecta mouse bone.
Vanleene M, Shefelbine S
Bone. 2013; 53(2):507-14.
PMID: 23352925
PMC: 3590448.
DOI: 10.1016/j.bone.2013.01.023.
Bone mineral density in children and young adults with neurofibromatosis type 1.
Lodish M, Dagalakis U, Sinaii N, Bornstein E, Kim A, Lokie K
Endocr Relat Cancer. 2012; 19(6):817-25.
PMID: 23089139
PMC: 4132947.
DOI: 10.1530/ERC-12-0293.
Imiglucerase in the treatment of Gaucher disease: a history and perspective.
Deegan P, Cox T
Drug Des Devel Ther. 2012; 6:81-106.
PMID: 22563238
PMC: 3340106.
DOI: 10.2147/DDDT.S14395.
Ultra-structural defects cause low bone matrix stiffness despite high mineralization in osteogenesis imperfecta mice.
Vanleene M, Porter A, Guillot P, Boyde A, Oyen M, Shefelbine S
Bone. 2012; 50(6):1317-23.
PMID: 22449447
PMC: 3407875.
DOI: 10.1016/j.bone.2012.03.007.
Osteoporosis guidelines miss big picture.
Vos E
CMAJ. 2011; 183(6):695.
PMID: 21464177
PMC: 3071395.
DOI: 10.1503/cmaj.111-2031.
Skeletal imaging effects of pamidronate therapy in osteosarcoma patients.
Price A, Abramson S, Hwang S, Chou A, Bartolotta R, Meyers P
Pediatr Radiol. 2010; 41(4):451-8.
PMID: 21052656
DOI: 10.1007/s00247-010-1883-4.
Alendronate treatment of the brtl osteogenesis imperfecta mouse improves femoral geometry and load response before fracture but decreases predicted material properties and has detrimental effects on osteoblasts and bone formation.
Uveges T, Kozloff K, Ty J, Ledgard F, Raggio C, Gronowicz G
J Bone Miner Res. 2008; 24(5):849-59.
PMID: 19113917
PMC: 2672204.
DOI: 10.1359/jbmr.081238.
